Texas Representative and House Foreign Affairs Committee Chairman, Michael McCaul, has expressed concern over the recent Hamas attack on Israel and the failure of both U.S. intelligence agencies and Israeli agencies to recognize the attack beforehand. Rep. McCaul disclosed that Egypt had notified the Israelis three days prior about the potential for such an event, indicating … [Read more...] about Intelligence Failure in Recent Hamas Attack
Forex News
Inflation Shows Signs of Slowing, but Concerns Linger
Economists are predicting that inflation in the United States likely ticked down in September, following a slowdown in gasoline price growth and a decrease in used car costs. However, there are indications that certain categories closely monitored by the Federal Reserve, such as housing and other services, may still exhibit persistent strength. According to consensus … [Read more...] about Inflation Shows Signs of Slowing, but Concerns Linger
N. Brown Group Reports Loss Due to Restructuring Costs and Consumer Behavior
By Najat Kantouar N. Brown Group, the U.K. online retailer, announced a pretax loss for the current period due to restructuring costs and lower online orders. This decline in performance can be attributed to cautious consumer behavior and unseasonable weather conditions. The company reported a pretax loss of £4.1 million ($5 million), reflecting £4.5 million in restructuring … [Read more...] about N. Brown Group Reports Loss Due to Restructuring Costs and Consumer Behavior
U.S. Crude-Oil Inventories Set to See Slight Increase
According to a survey conducted by The Wall Street Journal, U.S. crude-oil inventories are expected to experience a small uptick from the previous week, as indicated by data from the Energy Department. Nine analysts and traders were polled, with their estimates revealing that U.S. commercial crude-oil stockpiles are projected to have increased by 900,000 barrels for the week … [Read more...] about U.S. Crude-Oil Inventories Set to See Slight Increase
Promising Results for Annovis Bio’s Phase 2/3 Study on Alzheimer’s Disease
By Adam L. Cataldo Annovis Bio, a clinical-stage drug platform company based in Berwyn, Pa., recently announced positive findings from an independent statistical group regarding its Phase 2/3 study on Alzheimer's disease. The company revealed that there is no need to include additional patients, allowing the study to continue as planned. Market Reaction and Future … [Read more...] about Promising Results for Annovis Bio’s Phase 2/3 Study on Alzheimer’s Disease
